Winning Health Technology Group Co., Ltd. (SHE:300253)
China · Delayed Price · Currency is CNY 9.54
+0.26 (2.80%)
May 8, 2026, 3:04 PM CST
SHE:300253 Market Cap
SHE:300253 has a market cap or net worth of 21 billion as of May 8, 2026. Its market cap has increased by 5.60% in one year.
Market Cap
21.00B
Enterprise Value
20.52B
Revenue
2.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.54
Market Cap Chart
Since August 18, 2011, SHE:300253's market cap has increased from 2.30B to 21.00B, an increase of 813.49%. That is a compound annual growth rate of 16.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 21.00B | 8.21% |
| Dec 31, 2025 | 19.41B | 24.79% |
| Dec 31, 2024 | 15.55B | 1.39% |
| Dec 29, 2023 | 15.34B | -30.06% |
| Dec 30, 2022 | 21.93B | -39.02% |
| Dec 31, 2021 | 35.97B | -3.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 356.26B |
| WuXi AppTec | 337.21B |
| Shenzhen Mindray Bio-Medical Electronics | 206.20B |
| Sichuan Biokin Pharmaceutical | 114.16B |
| China National Medicines Corporation | 21.56B |
| DaShenLin Pharmaceutical Group | 21.06B |
| Walvax Biotechnology | 21.03B |
| Wedge Industrial | 20.65B |